Regen Biopharma declares 1:1 dividend of Series A Preferred stock for all share classes

Regen BioPharma Inc

Board declared dividend of one share of Series A Preferred for each share of Common, Series A, AA, M, and NC Preferred owned.
Record date is February 3, 2026; payable on or about February 9, 2026.
Dividend payable in authorized but unissued Series A Preferred stock.
All shareholders of record as of Record Date will receive the dividend on a 1:1 basis.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.